Rockwell Medical (RMTI) Common Equity (2010 - 2026)

Rockwell Medical (RMTI) has reported Common Equity for 17 consecutive years, with $35.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Common Equity rose 15.38% year-over-year to $35.1 million; the trailing twelve-month figure through Jun 2026 stood at $35.1 million (up 15.38% YoY), and the FY2025 full-year result was $37.0 million, up 13.49% from the prior year.
• Common Equity eased to $35.1 million in Q2 2026 per RMTI's latest filing, from $35.9 million in the prior quarter.
• Across five years, Common Equity topped out at $37.0 million in Q3 2025 and bottomed at -$4.8 million in Q1 2022.
• Historically, Common Equity has averaged $23.5 million across 5 years, with a median of $22.5 million in 2023.
• The widest YoY moves for Common Equity: up 456.45% in 2022, down 118.36% in 2022.
• Over 5 years, Common Equity stood at $14.1 million in 2022, then jumped by 50.94% to $21.3 million in 2023, then soared by 53.05% to $32.6 million in 2024, then advanced by 13.49% to $37.0 million in 2025, then slipped by 5.13% to $35.1 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $35.1 million, $35.9 million, and $37.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.